Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
Boehringer Ingelheim
Express Scripts
Colorcon

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Chloroprocaine hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for chloroprocaine hydrochloride and what is the scope of patent protection?

Chloroprocaine hydrochloride is the generic ingredient in four branded drugs marketed by Hospira, West-ward Pharms Int, Fresenius Kabi Usa, and B Braun Medical Inc, and is included in five NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chloroprocaine hydrochloride has twenty-seven patent family members in twenty-four countries.

There are four drug master file entries for chloroprocaine hydrochloride. Four suppliers are listed for this compound.

Summary for chloroprocaine hydrochloride
Recent Clinical Trials for chloroprocaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
B. Braun Medical Inc.Phase 4
Oregon Health and Science UniversityPhase 4
University of Alabama at BirminghamPhase 2

See all chloroprocaine hydrochloride clinical trials

Pharmacology for chloroprocaine hydrochloride
Drug ClassEster Local Anesthetic
Physiological EffectLocal Anesthesia
Synonyms for chloroprocaine hydrochloride
[2-(4-Amino-2-chloro-benzoyloxy)-ethyl]-diethyl-ammonium; chloride
2-(Diethylamino)ethyl 4-amino-2-chlorobenzoate hydrochloride
2-(diethylamino)ethyl 4-amino-2-chlorobenzoate;hydrochloride
2-Diethylaminoethyl 4-amino-2-chlorobenzoate hydrochloride
2319AH
3858-89-7
858C897
AC1L9B0S
AKOS027382305
API0001960
BENZOIC ACID,4-AMINO-2-CHLORO-, 2-(DIETHYLAMINO)ETHYL ESTER
C13H19ClN2O2.ClH
CAS-3858-89-7
CHEBI:3637
CHEMBL944
Chloroprocaine Hcl
Chloroprocaine hydrochloride (USP)
chloroprocainhydrochlorid
CHLORPROCAINE CHLORIDE
D00732
DSSTox_CID_28521
DSSTox_GSID_48595
DSSTox_RID_82793
DTXSID6048595
LT7Z1YW11H
MolPort-006-115-755
NCGC00183273-01
Nesacaine (TN)
s4284
SCHEMBL24096
SW220257-1
Tox21_112925
UNII-LT7Z1YW11H
W-106476

US Patents and Regulatory Information for chloroprocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int CHLOROPROCAINE HYDROCHLORIDE chloroprocaine hydrochloride INJECTABLE;INJECTION 040273-001 Sep 9, 1998 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa NESACAINE-MPF chloroprocaine hydrochloride INJECTABLE;INJECTION 009435-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa NESACAINE chloroprocaine hydrochloride INJECTABLE;INJECTION 009435-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
B Braun Medical Inc CLOROTEKAL chloroprocaine hydrochloride SOLUTION;INTRATHECAL 208791-001 Sep 26, 2017 RX Yes No   Start Trial   Start Trial Y   Start Trial
West-ward Pharms Int CHLOROPROCAINE HYDROCHLORIDE chloroprocaine hydrochloride INJECTABLE;INJECTION 040273-002 Sep 9, 1998 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira CHLOROPROCAINE HYDROCHLORIDE chloroprocaine hydrochloride INJECTABLE;INJECTION 087446-001 Apr 16, 1982 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa NESACAINE-MPF chloroprocaine hydrochloride INJECTABLE;INJECTION 009435-007 May 2, 1996 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
McKinsey
Colorcon
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.